Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, Malaysian Institute Partner on Halal Food Safety, Authentication

NEW YORK (GenomeWeb News) – Agilent Technologies and Universiti Putra Malaysia announced on Wednesday a collaboration directed at improving the authentication and safety of halal food.

Agilent will provide its 6490 Triple Quadrupole Liquid Chromatography-Mass Spectrometry systems as well as competency training to the university's Halal Products Research Institute. Through the collaboration HPRI will "drive research into the development of methods for porcine-gelation screening and amino acids profiling, including adulteration analysis and confirmation," Agilent and the school said in a statement.

Financial and other terms of the deal, the first of its kind for Agilent in the South Asia Pacific region, were not disclosed.

Halal is a term designating that goods or actions comply with Islamic laws, and any food considered halal can be used and eaten by Muslims. Citing statistics from the World Halal Forum, the partners said that the halal food market is estimated at $662 billion annually, or almost 17 percent of the global food industry.

Previously, Agilent and the Malaysian government reached an agreement during the summer of 2010 to develop and promote biotechnology in that country with a focus on developing halal testing standards in pharmaceuticals and nutraceuticals.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more